A prospective real‐world study of the diffuse‐type tenosynovial giant cell tumor patient journey: A 2‐year observational analysis
Nicholas M. Bernthal(Harvard University), Michiel A. J. van de Sande(Leiden University Medical Center), John H. Healey(Memorial Sloan Kettering Cancer Center), Zachary D. C. Burke(Cleveland Clinic), Erik J. Geiger(Carolina Musculoskeletal Institute), Javier Martín‐Broto(Hospital Universitario Fundación Jiménez Díaz), Hans Gelderblom(Leiden University Medical Center), Sebastian Bauer(Science for Life Laboratory), Julio López‐Bastida(Daiichi Sankyo (Germany)), Elisabeth Beyerlein(Daiichi Sankyo (Germany)), Emanuela Palmerini(Istituto Ortopedico Rizzoli), Andreas Leithner(Medical University of Graz), F. Gouin(Centre Léon Bérard), Geert Spierenburg(Leiden University Medical Center), Xin Ye(Daiichi Sankyo (United States)), Petra Laeis(Daiichi Sankyo (Germany)), H.W.B. Schreuder(Radboud University Nijmegen), Eric L. Staals(Istituto Ortopedico Rizzoli)
Cited by 12
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Cremophor EL
|European Journal of Cancer|2001|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k